<?xml version="1.0" ?>
<proxyVoteTable xmlns="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <proxyTable>
    <issuerName>TEVA PHARMACEUTICAL INDS LTD</issuerName>
    <cusip>881624209</cusip>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>Proposal 2: To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs)</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>353580</sharesVoted>
    <sharesOnLoan>6659</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>353580</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>1</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>TEVA PHARMACEUTICAL INDS LTD</issuerName>
    <cusip>881624209</cusip>
    <meetingDate>05/28/2026</meetingDate>
    <voteDescription>Proposal 2: To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers (NEOs)</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>11110304</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>Against</howVoted>
        <sharesVoted>11110304</sharesVoted>
        <managementRecommendation>AGAINST</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>2</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
  <proxyTable>
    <issuerName>ORMAT TECHNOLOGIES, INC.</issuerName>
    <cusip>686688102</cusip>
    <meetingDate>06/02/2026</meetingDate>
    <voteDescription>Proposal 2: To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers</voteDescription>
    <voteCategories>
      <voteCategory>
        <categoryType>SECTION 14A SAY-ON-PAY VOTES</categoryType>
      </voteCategory>
    </voteCategories>
    <voteSource>ISSUER</voteSource>
    <sharesVoted>246648</sharesVoted>
    <sharesOnLoan>0</sharesOnLoan>
    <vote>
      <voteRecord>
        <howVoted>FOR</howVoted>
        <sharesVoted>246648</sharesVoted>
        <managementRecommendation>FOR</managementRecommendation>
      </voteRecord>
    </vote>
    <voteManager>
      <otherManagers>
        <otherManager>2</otherManager>
      </otherManagers>
    </voteManager>
  </proxyTable>
</proxyVoteTable>
